Missing/wrong data?
Log in to edit
Efficacy and safety of a two-drug direct-acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6
scientific article published on 11 July 2019
Author/s
author: Eric Lawitz, Maria Buti, Krzysztof Tomasiewicz
Work details
Publication date
July 11, 2019
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.